Yatai Pharma announced that the company plans to use its own funds and self-raised funds to buy back some shares through centralized bidding. The total buyback amount will be no less than 10 million yuan and no more than 20 million yuan, with a buyback price not exceeding 7.00 yuan per share. Based on the upper limit of the buyback amount, it is estimated that about 2.86 million shares can be repurchased, accounting for approximately 0.38% of the company's total share capital. The repurchased shares will be used for equity incentives or employee stock ownership plans. The buyback period shall not exceed 12 months from the date of approval by the board of directors.
Zhejiang Yatai Pharmaceutical Co LtdCompany announces share buyback for equity incentives, signaling confidence and supporting stock price.